Diverse <i>BRAF</i> Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity

Christina Stangl(Utrecht University), Wigard P. Kloosterman(Utrecht University)
Molecular Cancer Research
January 7, 2020
10.1158/1541-7786.mcr-19-0529
Cited by 19

Related Papers

Mapping and phasing of structural variation in patient genomes using nanopore sequencing
|Nature Communications|2017|438
Negative selection in humans and fruit flies involves synergistic epistasis
|Science|2017|134
WGS-based telomere length analysis in Dutch family trios implicates stronger maternal inheritance and a role for RRM1 gene
|Scientific Reports|2019|16